Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery

NCT01161641 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Extremely slow accural due to rarity of medical condition studied.

Conditions

Protein Losing Enteropathy

Interventions

DRUG: ODSH at 0.125 mg/kg/h
DRUG: ODSH at 0.375 mg/kg/h
DRUG: ODSH at 0.250 mg/kg/h

Sponsor

Jazz Pharmaceuticals